|
US3927208A
(en)
*
|
1973-05-14 |
1975-12-16 |
Rit Rech Ind Therapeut |
Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
|
|
US4631189A
(en)
|
1980-03-10 |
1986-12-23 |
Da Vinci Laboratories, a division of FoodScience Corporation |
N,N-dimethylglycine and use in immune response
|
|
JPS6013718A
(ja)
|
1983-07-05 |
1985-01-24 |
Chemo Sero Therapeut Res Inst |
Ｂ型肝炎ワクチン
|
|
JPS60193925A
(ja)
|
1984-03-13 |
1985-10-02 |
Chemo Sero Therapeut Res Inst |
凍結乾燥製剤化ワクチン
|
|
US4808700A
(en)
*
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
JPS61189228A
(ja)
|
1985-02-19 |
1986-08-22 |
Nippon Sekijiyuujishiya |
血液凝固第８因子製剤の製法
|
|
US4950596A
(en)
|
1985-03-04 |
1990-08-21 |
The Dow Chemical Company |
Stabilization of intracellular enzymes
|
|
JPS6238173A
(ja)
*
|
1985-08-13 |
1987-02-19 |
三菱レイヨン株式会社 |
抗血液凝固剤
|
|
US5169758A
(en)
|
1986-05-02 |
1992-12-08 |
Boehringer Mannheim Gmbh |
Stabilized, NAD(P)H-dependent, soluble nitrate reductase, a process for the preparation thereof and a reagent containing it
|
|
US4816568A
(en)
|
1986-05-16 |
1989-03-28 |
International Minerals & Chemical Corp. |
Stabilization of growth hormones
|
|
NZ221306A
(en)
|
1986-08-15 |
1990-02-26 |
Commw Scient Ind Res Org |
2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
|
|
US4980277A
(en)
|
1987-10-16 |
1990-12-25 |
Cultor Ltd. |
Cryoprotectant solution and method
|
|
WO1989011297A1
(en)
|
1988-05-27 |
1989-11-30 |
Centocor, Inc. |
Freeze-dried formulation for antibody products
|
|
GB8826429D0
(en)
|
1988-11-11 |
1988-12-14 |
Univ Leeds Ind Service Ltd |
Enzyme stabilisation systems
|
|
CA2065023A1
(en)
|
1989-08-15 |
1991-02-16 |
Brent Dorval |
Stabilized vaccine compositions
|
|
CA2051092C
(en)
|
1990-09-12 |
2002-07-23 |
Stephen A. Livesey |
Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions
|
|
AU2309692A
(en)
|
1991-07-03 |
1993-02-11 |
Cryolife, Inc. |
Method for stabilization of biomaterials
|
|
RU2099418C1
(ru)
*
|
1991-11-21 |
1997-12-20 |
Лонца Аг |
Фрагмент днк, обеспечивающий использование бетаина, рекомбинантная плазмидная днк с фрагментом днк, обеспечивающим использование бетаина, штамм бактерий rhizobium/agrobacterium, предназначенный для стабильного хранения плазмиды с фрагментом днк, способ получения штамма бактерий
|
|
ZA936095B
(en)
|
1992-08-21 |
1994-03-14 |
Univ Melbourne |
Cytokine applications.
|
|
FR2698879B1
(fr)
|
1992-12-09 |
1995-01-13 |
Rhone Poulenc Biochimie |
gellules modifiées au niveau du catabolisme de la bétaïne, préparation et utilisations, notamment pour la production de métabolites ou d'enzymes.
|
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
US5580856A
(en)
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
|
US5965438A
(en)
|
1995-06-07 |
1999-10-12 |
Phyton, Inc. |
Cryopreservation of plant cells
|
|
CA2226575C
(en)
|
1995-07-27 |
2011-10-18 |
Genentech, Inc. |
Stabile isotonic lyophilized protein formulation
|
|
GB9521806D0
(en)
*
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Preservation methods
|
|
FR2746109B1
(fr)
|
1996-03-12 |
1998-04-17 |
Rhone Poulenc Rorer Sa |
Milieu pour la conservation de materiel biologique
|
|
US20070179096A1
(en)
|
1996-04-24 |
2007-08-02 |
Novo Nordisk A/S |
Pharmaceutical Formulation
|
|
US6037116A
(en)
|
1996-06-14 |
2000-03-14 |
Biostore New Zealand, Ltd. |
Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials
|
|
CA2242035C
(en)
|
1997-07-01 |
2004-11-23 |
Transgene S.A. |
Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
|
|
AU5459698A
(en)
|
1997-11-26 |
1999-06-15 |
Universal Preservation Technologies, Inc. |
Preservation of sensitive biological samples by vitrification
|
|
DE69940354D1
(de)
|
1998-11-16 |
2009-03-12 |
Introgen Therapeutics Inc |
Adenovirus-formulierungen zur gentherapie
|
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
AUPQ347199A0
(en)
*
|
1999-10-15 |
1999-11-11 |
Csl Limited |
Novel polypeptide fragments
|
|
EP1289494A2
(en)
|
2000-06-08 |
2003-03-12 |
Powderject Vaccines, Inc. |
Powder compositions
|
|
DE10041515A1
(de)
|
2000-08-24 |
2002-03-14 |
Gerold Schuler |
Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
|
|
US20040110267A1
(en)
|
2000-12-15 |
2004-06-10 |
Stratagene |
Room temperature stable competent cells
|
|
CA2449593A1
(en)
|
2001-06-08 |
2002-12-19 |
Powderject Vaccines, Inc. |
Spray freeze-dried compositions
|
|
US7101693B2
(en)
|
2001-09-07 |
2006-09-05 |
Brigham Young University |
Plasticized hydrophilic glasses for improved stabilization of biological agents
|
|
JP4936618B2
(ja)
|
2001-09-21 |
2012-05-23 |
株式会社ノエビア |
微細エマルション組成物
|
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
DE60329070D1
(de)
|
2001-12-28 |
2009-10-15 |
Kyowa Hakko Kirin Co Ltd |
Antikörper gegen den fibroblastenwachstumsfaktor 23
|
|
EP3210624A1
(en)
|
2002-02-27 |
2017-08-30 |
Immunex Corporation |
Stabilized tnfr-fc composition comprising arginine
|
|
JP2003261591A
(ja)
|
2002-03-08 |
2003-09-19 |
Koji Hayade |
凍結乾燥安定剤
|
|
EP1539244A1
(en)
|
2002-06-27 |
2005-06-15 |
Novo Nordisk A/S |
Use of dimethyl sulfone as isotonicity agent
|
|
US20060228334A1
(en)
|
2002-07-10 |
2006-10-12 |
Manuel Rosa-Calatrava |
Modified adenoviral fiber with ablated to cellular receptors
|
|
WO2004035818A1
(en)
|
2002-10-21 |
2004-04-29 |
Biotage Ab |
Use of osmolytes to heat stabilise luciferase and/or apyrase
|
|
US7462700B2
(en)
|
2002-12-10 |
2008-12-09 |
Schering-Plough Animal Health Corporation |
Canine RANKL and methods for preparing and using the same
|
|
EP1633391B1
(en)
|
2003-06-03 |
2011-10-19 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
|
EP1638993A4
(en)
|
2003-06-10 |
2007-05-09 |
Univ Melbourne |
IMMUNOMODULATING COMPOSITIONS, APPLICATIONS THEREOF AND METHOD FOR THE PRODUCTION THEREOF
|
|
US20060247167A1
(en)
|
2003-09-01 |
2006-11-02 |
Novo Nordisk A/S |
Stable formulations of peptides
|
|
US7642077B2
(en)
|
2003-12-08 |
2010-01-05 |
Genencor International, Inc. |
Biocomposite comprising co-precipitate of enzyme, silicate and polyamine
|
|
EP1711619A4
(en)
|
2003-12-30 |
2007-04-11 |
Virumar Pituach Tarkivin Ltd |
INTEGRATED VIRUS COMPLEXES, METHOD FOR THE MANUFACTURE THEREOF, VACCINES CONTAINING THEM AND METHOD FOR THE USE THEREOF
|
|
CA2558676C
(en)
|
2004-03-03 |
2019-04-16 |
Essentia Biosystems, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
US20060058238A1
(en)
|
2004-09-15 |
2006-03-16 |
Lee Laurent-Applegate |
Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
|
|
EP2452670A1
(en)
|
2004-10-01 |
2012-05-16 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
CA2586846C
(en)
|
2004-11-10 |
2013-12-31 |
Qlt Usa Inc. |
A stabilized polymeric delivery system
|
|
BRPI0606867A2
(pt)
|
2005-01-28 |
2009-07-21 |
Wyeth Corp |
formulação lìquida; forma de dosagem unitária farmacêutica; kit; recipiente; método para aumentar a estabilidade de um polipeptìdeo de ligação a antìgeno numa formulação; método para preparar uma forma de dosagem unitária farmacêutica; formulação estável; formulação; e produto terapêutico
|
|
GB0502661D0
(en)
|
2005-02-09 |
2005-03-16 |
Stabilitech Ltd |
A desiccated product
|
|
TWI398272B
(zh)
*
|
2005-03-08 |
2013-06-11 |
Intervet Int Bv |
化學定義的安定劑
|
|
CN101155914B
(zh)
|
2005-04-08 |
2013-03-06 |
阿戈斯治疗公司 |
树状细胞组合物和方法
|
|
PT1954308E
(pt)
|
2005-09-16 |
2011-11-03 |
Merial Ltd |
Estabilizadores para vacinas liofilizadas
|
|
EP1933867A1
(en)
|
2005-10-04 |
2008-06-25 |
Alk-Abello A/S |
Solid vaccine formulation
|
|
CN101360821A
(zh)
|
2005-11-21 |
2009-02-04 |
圣诺菲·帕斯图尔有限公司 |
重组病毒的稳定制剂
|
|
ES2352855T3
(es)
|
2005-11-30 |
2011-02-23 |
International Institute Of Cancer Immunology, Inc. |
Nuevos compuestos peptídicos del tumor de wilms.
|
|
WO2008051245A2
(en)
|
2005-12-02 |
2008-05-02 |
Novartis Ag |
Nanoparticles for use in immunogenic compositions
|
|
AU2007215012A1
(en)
|
2006-02-15 |
2007-08-23 |
Imclone Llc |
Antibody formulation
|
|
US8021659B2
(en)
|
2006-04-28 |
2011-09-20 |
Naidu Lp |
Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
|
|
ES2286951B1
(es)
|
2006-05-26 |
2008-10-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A |
Nanoparticulas bioadhesivas para la administracion de moleculas biologicamente activas.
|
|
US20090053197A1
(en)
|
2006-06-14 |
2009-02-26 |
Ramaekers Joseph C |
Transfer Factor Compositions and Methods
|
|
NZ576563A
(en)
*
|
2006-11-03 |
2012-09-28 |
Alphavax Inc |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
GB0705245D0
(en)
*
|
2007-03-19 |
2007-04-25 |
Stabilitech Ltd |
Stable biological products
|
|
CA2681567C
(en)
|
2007-03-22 |
2016-07-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
|
|
JP2010530846A
(ja)
|
2007-06-01 |
2010-09-16 |
アコロジックス インコーポレイティッド |
高温で安定なペプチド製剤
|
|
WO2009006097A1
(en)
|
2007-06-29 |
2009-01-08 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Liquid protein formulations comprising gdf-5 for use at elevated temperatures
|
|
EP2192908A4
(en)
|
2007-07-25 |
2010-09-01 |
Bioe Inc |
DIFFERENTIATION OF PRECURSOR CELLS OF MULTIPLE ABSTRACTS AGAINST CHONDROCYTES
|
|
US20090123436A1
(en)
|
2007-11-08 |
2009-05-14 |
Surmodics, Inc. |
Cryopreservative compositions and methods
|
|
BRPI0911048A2
(pt)
|
2008-04-14 |
2015-12-29 |
Atrm Llc |
formulações líquidas tamponadas de gdf-5
|
|
WO2009131995A1
(en)
*
|
2008-04-21 |
2009-10-29 |
Nanobio Corporation |
Nanoemulsion influenza vaccine
|
|
BRPI0918988A2
(pt)
|
2008-09-24 |
2015-12-01 |
Stabilitech Ltd |
métodos para preservar um polipeptídeo e um imunógeno de vacina, e para preparar uma vacina, pó seco, produto preservado, frasco selado, ampola ou seringa, uso de um excipiente, e, vacina.
|
|
US20110212127A1
(en)
*
|
2008-09-24 |
2011-09-01 |
Stabilitech Ltd. |
Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
|
|
US8795686B2
(en)
|
2008-11-07 |
2014-08-05 |
Serum Institute Of India |
Stable, dried rotavirus vaccine, compositions and process for preparation thereof
|
|
EP2430195B1
(en)
|
2009-05-11 |
2019-01-23 |
Biomatrica, INC. |
Compositions and methods for biological sample storage
|
|
CN101670104A
(zh)
|
2009-09-24 |
2010-03-17 |
浙江大学 |
一种含人参皂甙的油佐剂及其制备方法
|
|
WO2011109415A2
(en)
|
2010-03-02 |
2011-09-09 |
Amgen Inc. |
Reducing viscosity of pharmaceutical formulations
|
|
HUE026885T2
(en)
*
|
2010-03-31 |
2016-08-29 |
Stabilitech Ltd |
Stabilize virus fragments
|
|
BR112012025047A2
(pt)
|
2010-03-31 |
2016-06-21 |
Stabilitech Ltd |
formulações líquidas estabilizadas
|
|
EP2552410B1
(en)
|
2010-03-31 |
2018-10-24 |
Stabilitech Biopharma Ltd |
Method for preserving alum adjuvants and alum-adjuvanted vaccines
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
GB201406569D0
(en)
*
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
BR112019014004A2
(pt)
|
2017-01-06 |
2020-02-11 |
Stabilitech Biopharma Ltd |
Método de fornecimento de transgene, comprimido ou cápsula, método de preparação de partículas virais e produto
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|